More on GLUE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (5/8/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Monte Rosa Therapeutics (NQ:GLUE)
Delayed: 17.80 -0.15 (0.84%)
Prev. Close $17.95  
Open$17.17 
52 Wk High$ 
52 Wk Low$ 
Day High$18.23 
Day Low$17.14 
P/E N/A  
EPS$ 
Volume864,633 

Friends, Peers and Foes (?): NVS, NOVN, NOVNEE, NVSEF, NVSN (more...)

Mar 5, 2026 05:24 PM Form 4 Monte Rosa Therapeutics, For: Mar 04 Filed by: Dunn Edmund
Mar 4, 2026 04:50 PM Form 4 Monte Rosa Therapeutics, For: Mar 02 Filed by: Warmuth Markus
Mar 4, 2026 04:45 PM Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Mar 2, 2026 05:03 PM Form 4 Monte Rosa Therapeutics, For: Feb 27 Filed by: Dunn Edmund
Mar 2, 2026 04:25 PM Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Mar 2, 2026 04:16 PM Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Feb 27, 2026 04:29 PM Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Feb 24, 2026 04:06 PM Form 4 Monte Rosa Therapeutics, For: Feb 23 Filed by: Janku Filip
Feb 24, 2026 07:01 AM Monte Rosa shows positive results for prostate cancer drug combination
Feb 24, 2026 07:01 AM Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients
View All Articles

Entities mentioned with GLUE

View All Entities